Posted in Blog
... Faustman's BCG trials to cure Diabetes type 1 (D1). I told her that even though there had previously been 20 years of safety testing on mice of this compound (BCG – Bacillus Calmette Guerin), an ...
Posted in Blog
... Why would repeating phase 1 and less for 5 years NOT be an obviously ludicrous waste of time?
Something so obviously un-scientific as the restrictions of Phase 2 makes one wonder at the ridiculousnes ...
Posted in Comments
... sclerosis (Phase II trials) showed amazing effects when patients are followed out 5 years so the BCG drug can have long lasting therapeutic effects in autoimmunity that are now are allowing Phase III testing ...
Posted in Blog
... ly used reasonable and fair? Was the amount of BCG given in Phase 1 too small to encourage a therapeutic response, considering the safety record of BCG (80 years with ONE BILLION people treated ...
Posted in Comments
... still has three large, red, stained marks along the veins, where I did the injections, even two years later I still wear long sleeve shirts to work because it makes me look like a junkee. I rarely go to ...
Posted in Comments
As a type I diabetic for I don't know how many years (20+), I've been always told that a cure would be found within five years. Many five years have passed and we have nothing. I was also told many tim ...
Posted in Blog
... work for Pharma a few years, then for the FDA, then back again. For example, the current Head Commissioner of the FDA has been paid huge amounts in consultation fees for an amalgam filling company. ...
Posted in Blog
... long term safety record (ninety, 90) years, how would anyone know unless someone tries it?
I’m not sure how the ...
Posted in Blog
... work of most other scientists who are locked into the promotion of embryonic stem cell research - for which JDRF has lobbied aggressively.
Dr. Faustman says: "Four years ago, nobody believed ...
Posted in Blog
... of royalty agreements (as stated above) to JDRF for a period of three years after the expiration of the JDRF grant in question.
Unless otherwise indicated or requested by the grantee institution, ...
Posted in Blog
Economic Benefits of Curing Diabetes type1
Communication – Diabetics Dia-logue
Those of us who have been diabetic for 20 years or more have seen tremendous changes in how we communicate with each ...
Posted in Blog
... because we assumed that if you popped in these islet cells from organ donors, you could cure diabetes.
Within three years, we realized it wasn’t working. So we thought "Let’s think ...
Posted in Comments
... Faustman's studies up until now, I'm sure she would have had to fold up her research years ago. Point is, beyond our individual $s, seeing Dr Faustman's effort mature into a viable solution ...
Posted in Blog
... You were young, and it was a big change. You were told that research was madly happening, but that it would be another 10 years before we got any results at all. Along the way, you went ...
Posted in Blog
... pancreatic beta-cell responses. We randomly assigned patients with long-term type 1 diabetes (mean 15-years duration) to repeated BCG vaccinations (n=3) or placebo (n=3) in this 20-week double-blinde ...
Posted in Blog
... obvious symptom relief. They could now walk, dress themselves and do tasks they hadn’t been able to in years. Still, doctors were not allowed to do the procedure in the US and Canada. One blogger was aware ...
Posted in Homepage
... CJ. (1999). Issues relating to the use of BCG in immunization programs. Geneva: WHO)
Bacillus Calmette-Guerin (BCG) is a generic drug that has a safety profile of many years, and could ...